
Opinion|Videos|August 27, 2024
MonumenTAL-1: Long Term Follow up Efficacy
Author(s)Larysa Sanchez, MD, Samantha Shenoy, MSN, NP
Experts give an overview of long-term follow-up efficacy data from the MonumenTAL-1 study.
Advertisement
Episodes in this series

Advertisement
Related to this article

Oncology clinicians gathered to review relapsed CLL care options, CAR T-cell trial updates, and advanced practice provider roles.

Dr. Wendy Harpham reflects on her journey as a physician and patient, emphasizing precise clinical communication in oncology care.

FDA approves pirtobrutinib for untreated CLL/SLL without 17p deletion based on BRUIN CLL-313 data. Read key nursing safety takeaways.

Most oral blood cancer drug prescriptions were first rejected by insurers, and fill rates fell sharply when out-of-pocket costs topped $175.

At ASTRO 2026, Suresh Rana details how AI-driven contouring accelerates care timelines, requiring rigorous team monitoring and early nursing input.

At ASTRO 2026, Dr. Erica Braschi Jordan details toxicity tracking, physical therapy referral, and quality of life in proton regional nodal irradiation.

At ASTRO 2026, Dr. Mishaal Munir details how nurse-led triage workflows and prompt symptom escalations improve care for breast cancer brain metastases.
Advertisement
Advertisement
Trending on Oncology Nursing News
1
The Importance of Precise Clinical Communication in Oncology Nursing
2
FDA Approves Pirtobrutinib for Untreated CLL/SLL
3
Prior Authorization, Costs Limit Access to Oral Blood Cancer Drugs
4
ASTRO 2026: Dr. Erica Braschi Jordan Details Proton Regional Nodal Care Plan
5

